Screener
Candel Therapeutics, Inc. CADL Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
FAQ
- What is Candel Therapeutics, Inc.'s total assets?
- Candel Therapeutics, Inc. (CADL) reported total assets of $201.92M in Q1 2026.
- How has Candel Therapeutics, Inc.'s total assets changed year-over-year?
- Candel Therapeutics, Inc.'s total assets increased by 110.5% year-over-year, from $95.91M to $201.92M.
- What is the long-term trend for Candel Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s total assets has grown at a 26.7% compound annual growth rate (CAGR), from $38.28M to $125.2M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Candel Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude